These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22262481)

  • 1. Both cyclin I and p35 are required for maximal survival benefit of cyclin-dependent kinase 5 in kidney podocytes.
    Taniguchi Y; Pippin JW; Hagmann H; Krofft RD; Chang AM; Zhang J; Terada Y; Brinkkoetter P; Shankland SJ
    Am J Physiol Renal Physiol; 2012 May; 302(9):F1161-71. PubMed ID: 22262481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells.
    Brinkkoetter PT; Olivier P; Wu JS; Henderson S; Krofft RD; Pippin JW; Hockenbery D; Roberts JM; Shankland SJ
    J Clin Invest; 2009 Oct; 119(10):3089-101. PubMed ID: 19729834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin I and p35 determine the subcellular distribution of Cdk5.
    Hagmann H; Taniguchi Y; Pippin JW; Kauerz HM; Benzing T; Shankland SJ; Brinkkoetter PT
    Am J Physiol Cell Physiol; 2015 Feb; 308(4):C339-47. PubMed ID: 25500740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin I-Cdk5 governs survival in post-mitotic cells.
    Brinkkoetter PT; Pippin JW; Shankland SJ
    Cell Cycle; 2010 May; 9(9):1729-31. PubMed ID: 20404535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p35, the non-cyclin activator of Cdk5, protects podocytes against apoptosis in vitro and in vivo.
    Brinkkoetter PT; Wu JS; Ohse T; Krofft RD; Schermer B; Benzing T; Pippin JW; Shankland SJ
    Kidney Int; 2010 Apr; 77(8):690-9. PubMed ID: 20130526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis.
    Zheng YL; Zhang X; Fu HX; Guo M; Shukla V; Amin ND; E J; Bao L; Luo HY; Li B; Lu XH; Gao YC
    PLoS One; 2016; 11(8):e0160252. PubMed ID: 27479491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway.
    Zhang Y; Li H; Hao J; Zhou Y; Liu W
    Exp Cell Res; 2014 Aug; 326(2):219-29. PubMed ID: 24768698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Atypical Cyclin-Dependent Kinase 5 (Cdk5) Guards Podocytes from Apoptosis in Glomerular Disease While Being Dispensable for Podocyte Development.
    Mangold N; Pippin J; Unnersjoe-Jess D; Koehler S; Shankland S; Brähler S; Schermer B; Benzing T; Brinkkoetter PT; Hagmann H
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinase 5 is a regulator of podocyte differentiation, proliferation, and morphology.
    Griffin SV; Hiromura K; Pippin J; Petermann AT; Blonski MJ; Krofft R; Takahashi S; Kulkarni AB; Shankland SJ
    Am J Pathol; 2004 Oct; 165(4):1175-85. PubMed ID: 15466384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nestin protects mouse podocytes against high glucose-induced apoptosis by a Cdk5-dependent mechanism.
    Liu W; Zhang Y; Hao J; Liu S; Liu Q; Zhao S; Shi Y; Duan H
    J Cell Biochem; 2012 Oct; 113(10):3186-96. PubMed ID: 22614921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclin-dependent kinase inhibitor p21 is required for TGF-beta1-induced podocyte apoptosis.
    Wada T; Pippin JW; Terada Y; Shankland SJ
    Kidney Int; 2005 Oct; 68(4):1618-29. PubMed ID: 16164639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-dependent kinase 5 contributes to endoplasmic reticulum stress induced podocyte apoptosis via promoting MEKK1 phosphorylation at Ser280 in diabetic nephropathy.
    Zhang Y; Gao X; Chen S; Zhao M; Chen J; Liu R; Cheng S; Qi M; Wang S; Liu W
    Cell Signal; 2017 Feb; 31():31-40. PubMed ID: 28024901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.
    Marshall CB; Krofft RD; Pippin JW; Shankland SJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1140-51. PubMed ID: 20130121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination.
    Takasugi T; Minegishi S; Asada A; Saito T; Kawahara H; Hisanaga S
    J Biol Chem; 2016 Feb; 291(9):4649-57. PubMed ID: 26631721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle regulatory proteins in podocyte health and disease.
    Marshall CB; Shankland SJ
    Nephron Exp Nephrol; 2007; 106(2):e51-9. PubMed ID: 17570940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nestin Improves Preeclampsia-Like Symptoms by Inhibiting Activity of Cyclin-Dependent Kinase 5.
    Yang X; Ding Y; Yang M; Yu L; Hu Y; Deng Y
    Kidney Blood Press Res; 2018; 43(2):616-627. PubMed ID: 29689548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.
    Dai C; Saleem MA; Holzman LB; Mathieson P; Liu Y
    Kidney Int; 2010 Jun; 77(11):962-73. PubMed ID: 20375988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35.
    Utreras E; Futatsugi A; Rudrabhatla P; Keller J; Iadarola MJ; Pant HC; Kulkarni AB
    J Biol Chem; 2009 Jan; 284(4):2275-84. PubMed ID: 19049962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
    Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
    J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between cdk5 and MEK-ERK signalling upon opioid receptor stimulation leads to upregulation of activator p25 and MEK1 inhibition in rat brain.
    Ramos-Miguel A; García-Sevilla JA
    Neuroscience; 2012 Jul; 215():17-30. PubMed ID: 22537847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.